Vaccinomics: current findings, challenges and novel approaches for vaccine development
about
Vaccinology in the third millennium: scientific and social challengesHuman Leukocyte Antigen Diversity: A Southern African PerspectiveClinical vaccine developmentOptiType: precision HLA typing from next-generation sequencing data.The future potential for cocaine vaccines.Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.Genetics and vaccines in the era of personalized medicine.Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremesThe Integration of Epistasis Network and Functional Interactions in a GWAS Implicates RXR Pathway Genes in the Immune Response to Smallpox Vaccine.Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approachReduced Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI).Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination.Theranostics in primary care: pharmacogenomics tests and beyond.Recent progress towards development of a Shigella vaccine.Systems approach to tuberculosis vaccine development.HLA-DRB1 the notorious gene in the mosaic of autoimmunity.A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations.Human Leukocyte Antigen-A, B, C, DRB1, and DQB1 Allele and Haplotype Frequencies in a Subset of 237 Donors in the South African Bone Marrow Registry.Genetics and Vaccinology
P2860
Q24261399-423BE200-53A4-44BC-B03B-691EB60DA2CFQ26782686-1F589B39-D258-4777-B05C-2DABF1966209Q27013155-B7A07064-19E1-48A7-8914-1A83369A609BQ30843963-A93BCFAC-C4AB-4B42-96AA-414839F3D339Q34132804-A411945F-1C03-431E-9705-D28B2AA1B99FQ35193959-3FE27C01-8FAD-4158-B357-B533E9348B38Q35548112-2F4D8E26-B0EF-4FCF-9059-BFC3D3E07678Q36010709-15D29552-C483-4F8C-88BD-CA9DCE2F0006Q36101391-7F1D31C6-A615-477A-BAC0-94D539A039BFQ36445635-67754414-D9A9-4EA8-8524-9A5C3EDC437AQ36538821-3965EA81-0952-4D85-BC70-8AF0C0AA1340Q36733384-0E851BD4-C202-45D8-8310-6633266F84E5Q37119456-04429C83-946D-41D1-AFC8-CE17EE7E2245Q37385591-A684622E-DFA2-44B2-AD06-4C78320F02BBQ38068223-543425D8-9217-4216-B8BF-3EAECC2794F5Q38068954-6CD209D7-2ACA-46C7-9AF9-244A6C6233C8Q38075096-69CD81B3-6D57-440C-9432-756F4F872467Q40607323-14482915-A298-4549-B688-A415A838003BQ42252783-B54144FB-36B0-4E46-A3AA-D8E9D5357B3FQ55116544-8D620116-CA3F-4E15-9B0F-2C0C1C7568D9Q56451891-B3BC846C-2DC7-457E-99FB-82D097F5C02B
P2860
Vaccinomics: current findings, challenges and novel approaches for vaccine development
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vaccinomics: current findings, challenges and novel approaches for vaccine development
@ast
Vaccinomics: current findings, challenges and novel approaches for vaccine development
@en
type
label
Vaccinomics: current findings, challenges and novel approaches for vaccine development
@ast
Vaccinomics: current findings, challenges and novel approaches for vaccine development
@en
prefLabel
Vaccinomics: current findings, challenges and novel approaches for vaccine development
@ast
Vaccinomics: current findings, challenges and novel approaches for vaccine development
@en
P2860
P1433
P1476
Vaccinomics: current findings, challenges and novel approaches for vaccine development
@en
P2860
P2888
P304
P356
10.1208/S12248-011-9281-X
P407
P577
2011-06-14T00:00:00Z
P5875
P6179
1013154758